Invion Limited (FRA:7C8)

Germany · Delayed Price · Currency is EUR

0.0210

0.00 (0.00%)

Last updated: Oct 23, 2026, 8:06 AM CEST

Market Cap	2.54M -43.0%
Revenue (ttm)	232.95K
Net Income	-3.41M
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Open	0.0210
Previous Close	0.0210
Day's Range	0.0210 - 0.0210
52-Week Range	0.0200 - 0.0670
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 25, 2026

About Invion

Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in South Korea. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme (GBM), lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2000

Employees 4

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 7C8

Financial Performance

Financial numbers in AUD Financial Statements